Protagonist Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTGX and other ETFs, options, and stocks.

About PTGX

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943.

CEO

Dinesh V. Patel

CEODinesh V. Patel

Employees

126

Employees126

Headquarters

Newark, California

HeadquartersNewark, California

Founded

2006

Founded2006

Employees

126

Employees126

PTGX Key Statistics

Market cap

3.44B

Market cap3.44B

Price-Earnings ratio

74.19

Price-Earnings ratio74.19

Dividend yield

—

Dividend yield—

Average volume

650.71K

Average volume650.71K

High today

$56.89

High today$56.89

Low today

$55.18

Low today$55.18

Open price

$56.83

Open price$56.83

Volume

457.07K

Volume457.07K

52 Week high

$60.60

52 Week high$60.60

52 Week low

$32.50

52 Week low$32.50

Analyst ratings

92%

of 12 ratings

Buy

91.7%

Hold

8.3%

Sell

People also own

Based on the portfolios of people who own PTGX. This list is generated using Robinhood data, and it’s not a recommendation.